INSIGHTS ON CLINICAL TRIAL PARTNERING

• The Future Of Oncology Research: Trends And Predictions

  In a clinical trial landscape defined by innovation and empathy, oncology CROs are essential to shaping the future of cancer research.

• Building Bioanalysis Infrastructure For Modern Drug Development

  Drug development accelerates with AI, decentralized trials, and adaptive protocols, but legacy CRO infrastructure lags. Platform-based systems enable speed, quality, automation, and continuous improvement.

• Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them

  Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.

• Targeted Protein Degraders: Transforming Oral Therapeutics

  CDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.

• How Sponsors Can Leverage New Technologies To Lower Trial Costs

  1/6/2025

  This study introduces sponsors to an innovative, lean, and efficient approach to data management that integrates site-facing technologies to streamline trial operations.

• Expand Bandwidth With A Trusted Regulatory Writing Partner

  9/18/2025

  Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.

• Stipends Create More Tax Burden — Here's A Better Option

  7/22/2025

  Explore the tax reporting requirements, including the threshold for payments requiring a 1099 form rising from $600 to $2,000 in 2026.

• Top 3 Tips For Choosing The Right Oncology CRO

  5/14/2025

  From complex study designs and evolving regulations to time-sensitive treatment protocols, advancing oncology clinical trials present significant challenges for investigators, sites, and patients.

• Overcoming Issues Of Non-Enrolling Sites In Clinical Trials

  1/14/2025

  Explore the challenges of non-enrolling sites in clinical trials, focusing on the benefits of leveraging artificial intelligence (AI) and machine learning (ML) in addressing those issues.